Abstract
Currently, the implantable cardioverter-defibrillator (ICD) is frequently used to treat patients with life-threatening ventricular arrhythmias. The incidence of ventricular tachycardia and ventricular fibrillation is particularly high in patients with poor left ventricular function [1, 2]. These arrhythmias are the main cause of death in patients with heart failure due to poor left ventricular function [3, 4]. Overall survival after ICD implantation largely depends on the type of underlying cardiac disease and the degree of left ventricular dysfunction [5]. Mean left ventricular ejection fraction in the larger ICD series [6–9] ranges from 29 to 34%. The prevention of sudden cardiac death in patients with low ejection fraction may contribute to further increase in the number of patients with heart failure. It is therefore apparent that the combination of an ICD with another treatment modality to reduce or to prevent pump failure could supply a need to improve functional capacity and quality of life, and possibly also survival in patients with impaired myocardial performance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chakko CS, Gheorghiade M. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J 1985; 109: 497–504.
Bigger JT, Jr. Relation between left ventricular dysfunction and ventricular arrhythmias after myocardial infarction. Am J Cardiol 1986; 57: 8B–14B.
Franciosa JA, Wilen M, Ziesche S et al. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831–6.
Packer M. Sudden unexpected death in patients with congestive heart failure: A second frontier. Circulation 1985; 72: 618–5.
Mehta D, Saksena S, Krol RB et al. Device use patterns and clinical outcome of implantable cardioverter defibrillator patients with moderate and severe impairment of left ventricular function. PACE 1993; 16 (Pt II): 179–85.
Winkle R, Mead R, Ruder M et al. Long-term outcome with the automatic implantable cardioverter defibrillator. J Am Coll Cardiol 1989; 13: 1353–63.
Klein H, Tröster J, Trappe H et al. Der Implantierbare automatische Kardioverter-Defibrillator (AICD). Herz Kardiovaskulaire Erkrankungen 1990; 15: 111–25.
Nisam S, Mower M, Moser S. ICD Clinical Update: First Decade, Initial 10,000 Patients. PACE 1991; 14(Pt. II): 255–62.
Akhtar M, Avitall B, Jazayeri M et al. Role of implantable cardioverter defibrillator therapy in the management of high-risk patients. Circulation 1992; 85(1): 1131–9.
Mehta D, Gilmour S, Ward DE, Camm AJ. Optimal atrioventricular delay at rest and during exercise in patients with dual chamber pacemakers: a non-invasive assessment by continuos wave Doppler. Br Heart J 1989; 61: 161–6.
Iwase M, Sotobata, I, Yokota M et al. Evaluation by pulsed Doppler echocardiography of the atrial contribution to left ventricular filling in patients with DDD pacemakers. Am J Cardiol 1986; 58: 104–9.
Panidis IP, Ross J, Munley B, Nestico P, Mintz GS. Diastolic mitral regurgitation in patients with atrioventricular conduction abnormalities: a common finding by pulsed Doppler echocardiography and its association with complete heart block. Am J Cardiol 1986; 57: 692–4.
Xiao HB, Brecker SJD, Gibson DG. Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy. Br Heart J 1992; 68: 403–7.
Iskandrian AS, Hakki AH, Bemis CE, Kane SA, Boston B, Amenta A. Left ventricular end-systolic pressure-volume relation: a combined radionuclide and hemodynamic study. Am J Cardiol 1983; 51: 1057–61.
Iskandrian AS, Bemis CE, Hakki AH, Heo J, Kimbiris D, Mintz GS. Ventricular systolic and diastolic impairment during pacing-induced myocardial ischemia in coronary artery disease: simultaneous hemodynamic, electrocardiographic and radionuclide angiographic evaluation. Am Heart J 1986; 112: 382–91.
Aroesty JM, McKay RG, Heller GV, Royal HD, Als AV, Grossman W. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Circulation 1985; 71: 889–900.
Feldman MD, Alderman JD, Aroesty JM et al. Depression of systolic and diastolic myocar¬dial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. J Clin Invest 1988; 82: 1661–9.
Grossman W, McLaurin LP, Rolett EL. Alteration in left ventricular relaxation and diastolic compliance in congestive cardiomyopathy. Cardiovasc Res 1979; 13: 514–22.
Erbel R, Schweizer P, Krebs W, Langen HJ, Meyer J, Effert S. Effects of heart rate changes on left ventricular volume and ejection fraction: A 2-dimensional echocardiography study. Am J Cardiol 1984; 53: 590–7.
Hochleitner M, Hörtnagl H, Ng CK, Hörtnagl H, Gschnitzer F, Zechmann W. Usefulness of physiologic dual chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 66: 198–202.
Brecker SJD, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992; 340: 1308–12.
Hochleitner M, Hörtnagl H, Hörtnagl H, Fridrich L, Gschnitzer F. Long-term efficacy of physiologie dual-chamber pacing in the treatment of end-stage idiopathic dilated car-diomyopathy. Am J Cardiol 1992; 70: 1320–5.
Linde C, Gadler F, Edner M, Nordländer R, Rosenqvist M, Rydén L. Is DDD-pacing with a short AV delay a beneficial treatment in patients with severe heart failure. PACE 1993; 16: 1924.
Auricchio A, Sommariva L, Salo RW, Scafuri A, Chiariello L. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual- chamber pacing with shortened AV delay. PACE 1993; 16: 2034–43.
Feliciano Z, Fisher ML, Patten RD, Gottlieb SS, Gold MR. The optimal AV delay in heart failure patients. PACE 1993(Pt. II); 16: 884.
Cowell R, Morris-Thurgood J, Ilsley C, Paul V. Septal short AV delay pacing: additional hemodynamic improvements in heart failure. PACE 1994; 17(Pt. II): 1980–3.
Karpawich P, Justice C, Chang C-H et al. Septal ventricular pacing in the immature canine heart: A new perspective. Am Heart J 1991; 121: 827–33.
Greenberg B, Chatterjee K, Parmeley WW et al. The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J 1979, 98: 742–51.
Burchell HB. A clinical appraisal of atrial transport function. Lancet 1964; 1: 775–9.
Labovitz AJ, Williams GA, Redd RM et al. Noninvasive assessment of pacemaker hemodynamic by Doppler echocardiography: Importance of left atrial size. J Am Coll Cardiol 1985; 6: 196–200.
Foster AH, Gold MR, McLaughlin Js. Acute hemodynamic effects of atrio-biventricular pacing in humans. Ann Thorac Surg 1995; 59: 294–300.
Bakker P, de Jonge N, Klöpping C et al. Biventricular pacing in congestive heart failure. Clinical Research 1994; 42: 327A.
Bakker P, Chin A Sen K, de Jonge N et al. Biventricular pacing improves functional capacity in patients with end-stage congestive heart failure. PACE 1995; 18(Pt. II): 825.
Bakker PF, Meijburg H, de Jonge N et al. Beneficial effects of biventricular pacing in congestive heart failure. PACE 1994: 17(Pt. II): 318.
Cazeau S, Ritter S, Bakdach S et al. Four chamber pacing in dilated cardiomyopathy. PACE 1994; 17(Pt. II): 1974–9.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bakker, P.F.A. (1996). Can pump failure in ICD patients with low ejection fraction be avoided by adding new pacing modes to current ICD’s?. In: Oto, M.A. (eds) Practice and Progress in Cardiac Pacing and Electrophysiology. Developments in Cardiovascular Medicine, vol 183. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0219-0_33
Download citation
DOI: https://doi.org/10.1007/978-94-009-0219-0_33
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6582-5
Online ISBN: 978-94-009-0219-0
eBook Packages: Springer Book Archive